The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Cardisure 3.5 mg/ml Oral Solution for Dogs



Dechra Regulatory B.V.VPA22622/026/001

Main Information

Trade NameCardisure 3.5 mg/ml Oral Solution for Dogs
Active SubstancesPimobendan
Dosage FormOral solution
Licence HolderDechra Regulatory B.V.
Licence NumberVPA22622/026/001

Group Information

ATC CodeQC01CE90 pimobendan
Therapeutic ClassCardiovascular
SpeciesDogs

Status

License statusAuthorised
Licence Issued13/09/2019
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back